<DOC>
	<DOCNO>NCT00001689</DOCNO>
	<brief_summary>The pharmacokinetic behavior vincristine pediatric patient well characterize . The present study obtain detailed information vincristine pharmacokinetics patient treat standard risk ALL CCG protocols 1952/1962 . A limited sampling strategy develop , interpatient intrapatient variability vincristine pharmacokinetics child study . A correlation vincristine neurotoxicity vincristine pharmacokinetics seek .</brief_summary>
	<brief_title>A Pharmacokinetic Pharmacodynamic Study Vincristine Children With Leukemia</brief_title>
	<detailed_description>The pharmacokinetic behavior vincristine pediatric patient well characterize . The present study obtain detailed information vincristine pharmacokinetics patient treat standard risk ALL accord CCG protocols 1952/1962/1991 . A limited sampling strategy develop , interpatient intrapatient variability vincristine pharmacokinetics child study . A correlation vincristine neurotoxicity vincristine pharmacokinetics seek .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>INCLUSION CRITERIA : All patient 1 year less 10 year age . Patient must diagnose acute lymphoblastic leukemia . All CCG patient must enrol CCG 1952 , 1962 1991 protocol , treat accord CCG standard risk ALL protocol . NCI patient must treat accord CCG 1952 treatment standard risk ALL . Enrollment onto current trial ( CCG B9802 ) possible take place concurrently enrollment onto 1952/1962/1991 start treatment accord CCG standard risk ALL protocol . All patient legal guardian must sign document inform consent indicate awareness investigational nature risk study . EXCLUSION CRITERIA : Previous underlie peripheral neuropathy . Previous underlying central nervous system dysfunction . Children CNS toxicity attributable chemotherapeutic agent follow Purdue pegboard test .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2003</verification_date>
	<keyword>Neurotoxicity</keyword>
	<keyword>A.L.L .</keyword>
	<keyword>Limited Sampling</keyword>
	<keyword>Dose Individualization</keyword>
	<keyword>Vinca Alkaloids</keyword>
</DOC>